Showing results (351-360 of 372) with videos related to

Sort By:
Pageof 38
Molecular Cancer Therapeutics|June 3, 2022
Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing ConsortiumPooja Hingorani, Wendong Zhang, Zhongting Zhang, et al.
Cell Reports|October 21, 2020
SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic SignaturesCamille Tlemsani, Lorinc Pongor, Fathi Elloumi, et al.
Molecular Cancer Therapeutics|March 1, 2006
Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and functionCecile Rouleau, Andre Roy, Thia St Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008Paul Okunieff, Lisa A Kachnic, Louis S Constine, et al.
The Prostate|October 3, 2006
Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer modelSharon D Morgenbesser, Rajashree P McLaren, Brenda Richards, et al.
Experimental Cell Research|September 8, 2009
Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescenceAnn Byrne, Rajashree P McLaren, Paul Mason, et al.
Hemasphere|January 20, 2025
The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemiaBen Watts, Christopher M Smith, Kathryn Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2019
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALLKathryn Evans, JianXin Duan, Tara Pritchard, et al.
International Journal of Oncology|December 28, 2010
The chemosensitizing activity of inhibitors of glucosylceramide synthase is mediated primarily through modulation of P-gp functionLilly Chai, Rajashree P McLaren, Ann Byrne, et al.
Cancer Research|October 26, 2018
The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line PanelAnne Monks, Yingdong Zhao, Curtis Hose, et al.
Pageof 38